Meag Munich Ergo’s Synopsys SNPS Stock Holding History

Meag Munich Ergo’s Portfolio SNPS Stock Details SNPS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$17.3M	Sell	33,712 -16,109	-32%	-$7.51M	0.49%	57
2025 Q1	$21.4M	Buy	49,821 +28,516	+134%	+$13.9M	0.63%	53
2024 Q4	$10.4M	Buy	21,305 +9,357	+78%	+$4.89M	0.33%	61
2024 Q3	$6.05M	Buy	+11,948	New	+$6.41M	0.19%	82
2024 Q1	–	Sell	-203	Closed	-$105K	–	201
2023 Q4	$105K	Hold	203	–	–	﹤0.01%	156
2023 Q3	$93.2K	Hold	203	–	–	﹤0.01%	161
2023 Q2	$88.4K	Buy	+203	New	+$81.8K	﹤0.01%	170
2020 Q1	–	Sell	-2,287	Closed	-$318K	–	453
2019 Q4	$318K	Sell	2,287 -8,102	-78%	-$1.11M	0.03%	345
2019 Q3	$1.41M	Buy	10,389 +4,998	+93%	+$676K	0.07%	292
2019 Q2	$678K	Hold	5,391	–	–	0.05%	340
2019 Q1	$614K	Sell	5,391 -26,875	-83%	-$2.66M	0.05%	343
2018 Q4	$2.69M	Hold	32,266	–	–	0.33%	81
2018 Q3	$3.17M	Buy	32,266 +25,316	+364%	+$2.41M	0.19%	156
2018 Q2	$596K	Sell	6,950 -51,102	-88%	-$4.45M	0.04%	312
2018 Q1	$4.76M	Buy	58,052 +32,670	+129%	+$2.87M	0.19%	160
2017 Q4	$2.19M	Buy	+25,382	New	+$2.2M	0.08%	270

Other funds holding SNPS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Edgewood Management Greenwich, Connecticut $15.5B AUM 9.67% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Meag Munich Ergo's SNPS Position: Q2 2025 in Review

Meag Munich Ergo reduced its Synopsys (SNPS) stake by 32% in Q2 2025, selling an estimated $7.51M and leaving 33,712 shares worth $17.3M. The position accounts for 0.49% of the portfolio, ranked #57.

Meag Munich Ergo first reported a position in SNPS in Q4 2017 and has held it in 16 quarters since. The position peaked at $21.4M in Q1 2025. 1,294 funds tracked by Wall St. Rank hold SNPS as of Q2 2025.

Meag Munich Ergo held 33,712 shares of Synopsys worth $17.3M as of Q2 2025.
Meag Munich Ergo sold 16,109 Synopsys shares in Q2 2025, an estimated $7.51M.
Synopsys made up 0.49% of Meag Munich Ergo's portfolio in Q2 2025, its #57 holding.
Meag Munich Ergo first reported a position in Synopsys in Q4 2017 and has held it in 16 quarters since.
Meag Munich Ergo's Synopsys position peaked at $21.4M in Q1 2025.
1,294 funds tracked by Wall St. Rank held Synopsys as of Q2 2025.

Based on Meag Munich Ergo's 13F filing for Q2 2025, filed 16 Jul 2025.